Evolution of Epstein–Barr Virus Infection Seroprevalence in a French University Hospital over 11 Years, Including the COVID-19 Pandemic, 2013–2023
<i>Epstein–Barr virus</i> (EBV) is one of the most prevalent human viruses worldwide. The COVID-19 pandemic, with its social distancing measures, has disrupted the circulation of many viruses. Delayed EBV primary infection is known to increase the risk of secondary conditions, including...
Saved in:
| Main Authors: | Aurélien Aubry, Catherine Francois, Baptiste Demey, Marie Louchet-Ducoroy, Christine Pannier, Christine Segard, Etienne Brochot, Sandrine Castelain |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Microorganisms |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-2607/13/4/733 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
How Epstein Barr Virus Causes Lymphomas
by: Ya-Fang Chiu, et al.
Published: (2024-11-01) -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
by: Helen Heslop, et al.
Published: (2009-11-01) -
Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome
by: Lorenza Torti, et al.
Published: (2012-01-01) -
Seroprevalence and Risk Factors for Epstein-Barr Virus Infection in Adults
by: Jale ALTINTAŞ, et al.
Published: (2017-12-01) -
Epstein-Barr Virus in Patients with Classical Hodgkin’s Lymphoma
by: VE Gurtsevitch, et al.
Published: (2018-04-01)